Levodopa-Induced Hyperhomocysteinemia and Cardiovascular Dysfunction in Parkinson’s Disease

  • Kelly L. Sullivan
  • , Theresa A. Zesiewicz
  • , B. Glunta
  • , Robert A. Hauser
  • , Michael Hoffmann
  • , Philip A. Wallach

Research output: Contribution to journalArticlepeer-review

Abstract

This conference abstract was published in Proceedings of the Movement Disorder Society International Congress of Parkinson's Disease and Movement Disorders .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Public Health

Keywords

  • Cardiovascular Dysfunction
  • Parkinson's Disease

Fingerprint

Dive into the research topics of 'Levodopa-Induced Hyperhomocysteinemia and Cardiovascular Dysfunction in Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this